Drug Utilisation Sub-Committee Outcome Statement 4-5 October 2012

First Page		Document Content
Date: 2015-03-20 01:07:13 Pharmaceutical Benefits Scheme Pharmaceuticals policy Quality use of medicines Osteoporosis Antidepressant Antipsychotic Attention deficit hyperactivity disorder Smoking cessation Health Medicine Healthcare in Australia		Drug Utilisation Sub-Committee Outcome Statement 4-5 October 2012 Add to Reading List Source URL: www.pbs.gov.au Download Document from Source Website File Size: 83,00 KB Share Document on Facebook

	GPA INFO plus Safe and quality use of medicines To enable best practice prescribing measures, it is imperative that GPs and clinical staff have access to current guidelines and the latest information on medicines. Patie DocID: 1mOkR - View Document
	Concept Paper on Guideline on quality and equivalence of topical product - amended DocID: 1giHZ - View Document
	viewpoint Improving medicine selection for older people J Simon Bell David G Le Couteur DocID: 184w2 - View Document
	Public Summary Document – November 2014 PBAC MeetingBUPRENORPHINE + NALOXONE 4mg/1mg film: sublingual, 12mg/3mg film: sublingual, Suboxone® sublingual film; Reckitt Benckiser Pty Ltd. 1 DocID: 17G6v - View Document
	Quality use of medicines Appropriate antibiotic prescribing - resources and CPD ... Quality use of medicines requires professional knowledge and skills around diagnosis of symptoms, available management options including DocID: 17FZh - View Document